Early Life Course of Children with Congenital Structural Heart Anomalies09/30/2022 - 09/29/2026 (PI)
HHS/Center for Disease Control5 NU50DD000111-03-00
Association of maternal, fetal and placental biomarkers with neonatal neuroimaging and development following in-utero opioid exposure09/01/2023 - 08/31/2026 (Subcontract PI)
Boston Medical Center Corporation NIH NICHD1R01HD113143-01
Massachusetts Center for Birth Defects Research and Prevention (BD STEPS) - Component A: BD-STEPS Core and Component B: BD-STEPS Stillbirth10/27/2023 - 06/30/2025 (Subcontract PI)
Comm. of Mass./Department of Public Health HHS CDC
Patient-provider racial concordance at birth & severe maternal morbidity among patients with hypertensive disorders of pregnancy04/01/2023 - 03/31/2024 (Multi-PI)
PI:
Martha Werler, DScBoston Medical Center Corporation American Heart Assoc
Massachusetts Center for Birth Defects Research and Prevention (BD STEPS) - Core02/28/2019 - 08/31/2023 (Subcontract PI)
Comm. of Mass./Department of Public Health HHS CDC5U01DD001224-03-00
Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with opioid use disorder10/01/2018 - 05/31/2023 (Subcontract PI)
Boston Medical Center Corporation NIH NICHD5R01HD096798-05
Pregnancy in women with congenital physical disabilities: Risk factors, birth outcomes, and mediation04/01/2019 - 03/31/2022 (PI)
NIH/National Institute of Child Health & Human Development5R03HD098507-02
A Population-Based Study to Quantify the Risks of Opioid Analgesics in Pregnancy09/01/2020 - 08/31/2021 (Subcontract PI)
Queen's University at Kingston NIH NICHD5R03HD099617-02
A Population-Based Study to Quantify the Risks of Opioid Analgesics in Pregnancy09/12/2019 - 08/31/2020 (Subcontract PI)
Queen's University at Kingston NIH NICHD1R03HD099617-01
Exploring Modifiable Factors for Folic Acid Resistant Spina Bifida09/01/2015 - 04/30/2019 (PI)
HHS/CDC/National Center for Birth Defects and Developmental Disabilities6 U01DD001184-03-03
Showing 10 of 20 results.
Show All Results
Society for Pediatric and Perinatal Epidemiologic Research04/01/2014 - 03/31/2019 (PI)
NIH/National Institute of Child Health & Human Development5R13HD055094-12
Zika Virus Colombia Cohort Study09/01/2017 - 05/31/2018 (Multi-PI)
PI:
Martha Werler, DScVysnova Partners Inc., HHS CDC
BURPPE: BU REPRODUCTIVE, PERINATAL, AND PEDIATRIC EPIDEMIOLOGY TRAINING PROGRAM05/01/2016 - 08/31/2017 (PI)
NIH/National Institute of Child Health & Human Development4T32HD052458-10
Hemifacial Microsomia: Psychosocial and Other Sequelae07/02/2010 - 06/30/2017 (PI)
NIH/National Institute of Dental & Craniofacial Research3R01DE011939-16S1
Comparative Safety of Buprenorphine vs. Methadone in Pregnancy09/30/2014 - 04/30/2017 (Subcontract PI)
Queen's University at Kingston NIH NICHD1R21JD081271-01
BURPPE: BU REPRODUCTIVE, PERINATAL, AND PEDIATRIC EPIDEMIOLOGY TRAINING PROGRAM05/01/2012 - 04/30/2017 (PI)
NIH/National Institute of Child Health & Human Development5T32HD052458-09
Nested case-control study of maternal herpes viruses in relation to gastroschisis04/10/2013 - 03/31/2016 (PI)
NIH/National Institute of Child Health & Human Development5R21HD072460-02
Risk Factors for Folic Acid-Resistant Spina Bifida09/30/2010 - 09/29/2015 (PI)
HHS/Center for Disease Control5U01DD000697-04
BURPPE: BU REPRODUCTIVE, PERINATAL, AND PEDIATRIC EPIDEMIOLOGY TRAINING PROGRAM09/30/2007 - 04/30/2012 (PI)
NIH/National Institute of Child Health & Human Development5T32HD052458-05
Medication Use and Birth Defects in Western Australia03/01/2001 - 08/31/2001 (PI)
NIH/Fogarty International Center1 F06 TW05567 01